Intestinal Biotech Development provides leading-edge research services in digestive diseases. Our expertise includes all aspects of intestinal and hepatic inflammation, visceral pain, and metabolic issues. We are collaborating and partnering with an outstanding team of clinicians and a world-class academic research center dedicated to IBD.
At the forefront of the industry, Intestinal Biotech Development has teamed with leading researchers, pharmaceutical companies, and food ingredient companies to bring fertile ideas into marketed medicines and food ingredients.
A decade of progress
In the last decade, much progress has been observed in the treatment of digestive tract diseases, including inflammatory bowel disease (IBD). New strategies and advanced technology therapies have been established, but some unmet medical needs remain. More ambitious and demanding research for the patient’s benefit, new therapeutic targets, and innovative medicines are goals of researchers worldwide.
Health concerns for a worldwide population
Nutrition and digestive health are major concerns for a large population. Some food ingredients appear to have interesting properties that improve intestinal comfort.